Hm Payson & CO Abb Vie Inc. Transaction History

Hm Payson & CO

$5.37 Billion
Q1 2024

A detailed history of Hm Payson & CO transactions in Abb Vie Inc. stock. As of the latest transaction made, Hm Payson & CO holds 569,569 shares of ABBV stock, worth $97.7 Million. This represents 1.93% of its overall portfolio holdings.

Number of Shares

569,569

Previous 568,583 0.17%

Holding current value

$97.7 Million

Previous $88.1 Million 17.71%

% of portfolio

1.93%

Previous 1.83%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Jun 20, 2024	BUY	$159.82 - $182.1 $157,582 - $179,550	986 Added 0.17%	569,569 $104 Million
Q4 2023 Feb 13, 2024	BUY	$137.6 - $154.97 $3.48 Million - $3.92 Million	25,316 Added 4.66%	568,583 $88.1 Million
Q3 2023 Nov 06, 2023	BUY	$133.59 - $154.65 $797,799 - $923,569	5,972 Added 1.11%	543,267 $81 Million
Q2 2023 Jul 17, 2023	BUY	$132.51 - $164.9 $1.66 Million - $2.07 Million	12,553 Added 2.39%	537,295 $72.4 Million
Q1 2023 Apr 18, 2023	BUY	$144.61 - $166.54 $1.5 Million - $1.73 Million	10,405 Added 2.02%	524,742 $83.6 Million

Q4 2022 Feb 06, 2023	BUY	$138.31 - $165.87 $1.52 Million - $1.82 Million	10,982 Added 2.18%	514,337 $83.2 Million
Q3 2022 Oct 25, 2022	BUY	$134.21 - $153.93 $1.57 Million - $1.8 Million	11,684 Added 2.38%	503,355 $67.6 Million
Q2 2022 Aug 15, 2022	SELL	$137.62 - $174.96 $885,722 - $1.13 Million	-6,436 Reduced 1.29%	491,671 $75.3 Million
Q1 2022 May 12, 2022	BUY	$131.98 - $163.75 $2.48 Million - $3.08 Million	18,814 Added 3.93%	498,107 $80.7 Million
Q4 2021 Feb 15, 2022	SELL	$107.43 - $135.93 $2.73 Million - $3.45 Million	-25,416 Reduced 5.04%	479,293 $64.9 Million
Q3 2021 Nov 30, 2021	SELL	$106.4 - $120.78 $1.57 Million - $1.78 Million	-14,716 Reduced 2.83%	504,709 $54.4 Million
Q2 2021 Aug 17, 2021	BUY	$105.21 - $117.21 $3.03 Million - $3.38 Million	28,810 Added 5.87%	519,425 $58.5 Million
Q1 2021 Jun 15, 2021	BUY	$102.3 - $112.62 $138,616 - $152,600	1,355 Added 0.28%	490,615 $53.1 Million
Q4 2020 Mar 10, 2021	SELL	$80.49 - $108.67 $1.55 Million - $2.09 Million	-19,248 Reduced 3.79%	489,260 $52.4 Million
Q3 2020 Dec 21, 2020	BUY	$85.91 - $100.83 $12.6 Million - $14.8 Million	146,864 Added 40.61%	508,508 $44.5 Million
Q2 2020 Aug 13, 2020	BUY	$73.37 - $98.18 $424,959 - $568,658	5,792 Added 1.63%	361,644 $35.5 Million
Q1 2020 Jul 01, 2020	BUY	$64.5 - $97.79 $878,683 - $1.33 Million	13,623 Added 3.98%	355,852 $27.1 Million
Q4 2019 Feb 18, 2020	SELL	$72.13 - $90.25 $200,521 - $250,895	-2,780 Reduced 0.81%	342,229 $30.3 Million
Q3 2019 Nov 12, 2019	SELL	$62.98 - $75.72 $978,079 - $1.18 Million	-15,530 Reduced 4.31%	345,009 $26.1 Million
Q2 2019 Aug 15, 2019	BUY	$65.7 - $83.98 $9,395 - $12,009	143 Added 0.04%	360,539 $26.2 Million
Q1 2019 Jul 31, 2019	BUY	$77.14 - $90.79 $27.7 Million - $32.6 Million	359,616 Added 46104.62%	360,396 $29 Million
Q4 2018 Feb 15, 2019	SELL	$77.85 - $96.01 $25 Million - $30.8 Million	-320,721 Reduced 99.76%	780 $72,000
Q3 2018 Nov 30, 2018	SELL	$88.91 - $98.84 $2.02 Million - $2.24 Million	-22,681 Reduced 6.59%	321,501 $30.4 Million
Q2 2018 Aug 27, 2018	BUY	$89.78 - $106.23 $313,152 - $370,530	3,488 Added 1.02%	344,182 $31.9 Million
Q1 2018 May 14, 2018	BUY	$92.01 - $123.21 $11,409 - $15,278	124 Added 0.04%	340,694 $32.2 Million
Q4 2017 Feb 16, 2018	BUY	$89.56 - $98.21 $5.8 Million - $6.36 Million	64,766 Added 23.48%	340,570 $32.9 Million
Q3 2017 Nov 06, 2017	BUY	$69.85 - $89.22 $19.3 Million - $24.6 Million	275,804	275,804 $24.5 Million

Others Institutions Holding ABBV

# of Institutions

3,651

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $303B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hm Payson & CO, based on Form 13F filings with the SEC.

News

Stay updated on Hm Payson & CO with notifications on news.

Account